Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
ACG: Mortality associated with both early- and late-stage EO-CRC rose most significantly among young adults aged 20 to 44 years between 2000 and 2022, new research reveals.
ACG 2024: New study results indicate GLP-1 RAs have a potentially protective role to play in combating EO-CRC, the incidence of which is notably rising worldwide.
More than half of US adults who had a colonoscopy in past 5 years said they wish they knew more information before their first procedure.
Nearly 40% of adults aged 45 to 50 years completed a fecal immunochemical test within 3 months, according to a large retrospective study.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
Increases in CRC screening were higher in high socioeconomic status and metropolitan areas, according to a new large cohort study.
Cologuard Plus bests its previous iteration and demonstrates greater sensitivity and specificity for any CRC relative to fecal immunochemical tests.